Antibody Trials
-
{
- All
- News
- Videos
-
New Nipah Vaccine Proves Safe, Triggers Antibodies In Phase 1 Results: Lancet Study
A phase 1 randomised clinical trial of a novel Nipah virus vaccine, led by US researchers, may soon pave the way to prevent the deadly infection.
-
New UCLA Therapy Shows Promise in Preventing Heart Failure After Heart Attacks
UCLA’s Broad Center researchers have developed an antibody therapy to help the heart heal after a heart attack. This therapy, which blocks the ENPP1 protein, reduces scar tissue formation that can lead to heart failure. Early tests showed that treated animals had less scarring and a reduced risk of severe heart failure. With plans for human trial...
-
New HIV Vaccine Candidate Shows Promise In Early Trials
A new HIV vaccine candidate developed by the Duke Human Vaccine Institute showed promise in a phase 1 trial, generating broadly neutralizing antibodies and strong immune responses in 20 healthy participants.
-
This Japanese Company Is Working On World's First Drug To Grow New Teeth
The company is set to conduct clinical trials on healthy adults in July 2024 to verify the safety of its new drug.
-
Cancer Disappears From Every Patient's Body In Drug Trial In US: Report
A group of 12 rectal cancer patients showed no signs of a tumour after taking an antibody drug for six months, according to a surprise finding from an ongoing medical trial in the US that experts termed optimistic.
-
AstraZeneca, Given As Booster, Gives Higher Antibodies Against Omicron
AstraZeneca said on Thursday preliminary data from a trial it conducted on its COVID-19 shot, Vaxzevria, showed it generated a higher antibody response against the Omicron variant and others, including Beta, Delta, Alpha and Gamma, when given as a th
-
One Vaccine Makes More Antibodies Than Another. Does It Matter?
Ten months ago, the results of large clinical trials appeared almost too good to be true: Two messenger RNA vaccines reduced symptomatic Covid-19 cases by more than 90% in almost every group that got them.
-
Moderna Submits Application Before US Regulator For Covid Booster Shot
Moderna on Wednesday announced it had begun submitting an application to the US Food and Drug Administration to authorize a booster of its Covid vaccine after trial data showed a significant increase in antibodies against variants.
-
COVID-19 Antibody Discovered That Can Neutralise All Known SARS-CoV-2 Strains, Claim Researchers
Molecular Biology Consortium based at Berkeley Lab's Advanced Light Source (ALS) claims to have discovered an antibody that can neutralise all known SARS-CoV-2 strains, including the new mutants.
-
AstraZeneca Says Its Antibody Cocktail Prevents Covid In High-Risk Groups
AstraZeneca Plc's Covid-19 antibody cocktail was found to be 77% effective in preventing symptomatic Covid-19 in high-risk people in a key trial that could expand the range of drugs available to vulnerable groups.
-
New Nipah Vaccine Proves Safe, Triggers Antibodies In Phase 1 Results: Lancet Study
A phase 1 randomised clinical trial of a novel Nipah virus vaccine, led by US researchers, may soon pave the way to prevent the deadly infection.
-
New UCLA Therapy Shows Promise in Preventing Heart Failure After Heart Attacks
UCLA’s Broad Center researchers have developed an antibody therapy to help the heart heal after a heart attack. This therapy, which blocks the ENPP1 protein, reduces scar tissue formation that can lead to heart failure. Early tests showed that treated animals had less scarring and a reduced risk of severe heart failure. With plans for human trial...
-
New HIV Vaccine Candidate Shows Promise In Early Trials
A new HIV vaccine candidate developed by the Duke Human Vaccine Institute showed promise in a phase 1 trial, generating broadly neutralizing antibodies and strong immune responses in 20 healthy participants.
-
This Japanese Company Is Working On World's First Drug To Grow New Teeth
The company is set to conduct clinical trials on healthy adults in July 2024 to verify the safety of its new drug.
-
Cancer Disappears From Every Patient's Body In Drug Trial In US: Report
A group of 12 rectal cancer patients showed no signs of a tumour after taking an antibody drug for six months, according to a surprise finding from an ongoing medical trial in the US that experts termed optimistic.
-
AstraZeneca, Given As Booster, Gives Higher Antibodies Against Omicron
AstraZeneca said on Thursday preliminary data from a trial it conducted on its COVID-19 shot, Vaxzevria, showed it generated a higher antibody response against the Omicron variant and others, including Beta, Delta, Alpha and Gamma, when given as a th
-
One Vaccine Makes More Antibodies Than Another. Does It Matter?
Ten months ago, the results of large clinical trials appeared almost too good to be true: Two messenger RNA vaccines reduced symptomatic Covid-19 cases by more than 90% in almost every group that got them.
-
Moderna Submits Application Before US Regulator For Covid Booster Shot
Moderna on Wednesday announced it had begun submitting an application to the US Food and Drug Administration to authorize a booster of its Covid vaccine after trial data showed a significant increase in antibodies against variants.
-
COVID-19 Antibody Discovered That Can Neutralise All Known SARS-CoV-2 Strains, Claim Researchers
Molecular Biology Consortium based at Berkeley Lab's Advanced Light Source (ALS) claims to have discovered an antibody that can neutralise all known SARS-CoV-2 strains, including the new mutants.
-
AstraZeneca Says Its Antibody Cocktail Prevents Covid In High-Risk Groups
AstraZeneca Plc's Covid-19 antibody cocktail was found to be 77% effective in preventing symptomatic Covid-19 in high-risk people in a key trial that could expand the range of drugs available to vulnerable groups.
